BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31203662)

  • 21. Drug disposition in pathophysiological conditions.
    Gandhi A; Moorthy B; Ghose R
    Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenges of dealing with promiscuous drug-metabolizing enzymes, receptors and transporters.
    Ma Q; Lu AY
    Curr Drug Metab; 2008 Jun; 9(5):374-83. PubMed ID: 18537574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery.
    Masimirembwa CM; Thompson R; Andersson TB
    Comb Chem High Throughput Screen; 2001 May; 4(3):245-63. PubMed ID: 11375740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence.
    Kennedy M
    Clin Pharmacol Ther; 2008 Dec; 84(6):662-73. PubMed ID: 18971926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolving role of drug metabolism in drug discovery and development.
    Yengi LG; Leung L; Kao J
    Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
    Hattinger CM; Serra M
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
    Zeng Z; Zheng W; Hou P
    Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of on-line systems using drug metabolizing enzymes integrated into capillary electrophoresis.
    Nowak P; Woźniakiewicz M; Kościelniak P
    Electrophoresis; 2013 Sep; 34(18):2604-14. PubMed ID: 23775897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes.
    Jeong H
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):689-99. PubMed ID: 20367533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
    den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
    Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of drug metabolism.
    Nebert DW; Dieter MZ
    Pharmacology; 2000 Sep; 61(3):124-35. PubMed ID: 10971198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma.
    Picher EA; Wahajuddin M; Barth S; Chisholm J; Shipley J; Pors K
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INTEDE 2.0: the metabolic roadmap of drugs.
    Zhang Y; Liu X; Li F; Yin J; Yang H; Li X; Liu X; Chai X; Niu T; Zeng S; Jia Q; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1355-D1364. PubMed ID: 37930837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.
    Anwar-Mohamed A; Degenhardt OS; El Gendy MA; Seubert JM; Kleeberger SR; El-Kadi AO
    Toxicol In Vitro; 2011 Jun; 25(4):785-95. PubMed ID: 21281708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
    Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
    J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modulation of nuclear receptors on drug-metabolizing enzymes and transporters].
    Liu ZH; Li Y
    Yao Xue Xue Bao; 2012 Dec; 47(12):1575-81. PubMed ID: 23460960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.